Increased low density lipoprotein oxidation in stable kidney transplant recipients

Kidney International

Volumn 49, Issue 2, 1996, Pages 488-493

  Ghanem, Hosam ^a   Van Den Dorpel, Marinus A ^a   Weimar, Willem ^a   Man In 't Veld, Arie J ^a   El Kannishy, Mohammed H ^a   Jansen, Hans ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; OXIDATION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030045867     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.69     Document Type: Article

References (51)

1. LAZARUS JM, LOWRIE, EG, HAMPERS CL, MERRIL JP: Cardiovascular disease in uremic patients on hemodialysis. Kidney Int 7:167-175, 1975
2. KASISKE BL: Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84:985-992, 1988
3. LINDNER A, CHARRA B, SHERRARD DJ, SCRIBNER BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697-701, 1974
4. IBELS LS, STEWART JH, MAHONY JF, NEALE FC, SHEIL AGR: Occlusive arterial disease in uraemic and haemodialysed patients and renal transplant recipients. Q J Med 182:197-214, 1977
5. CURTIS JJ: Hypertension and kidney transplantation. Am J Kidney Dis 7:181-196, 1986
6. CHAPMAN JR, MARCEN R, ARIAZ M, RAINE AEG, DUNNILL MS, MORRIS PJ: Hypertension after renal transplantation. A comparison of cyclosporin and conventional immunosuppression. Transplantation 43:860-864, 1987
7. CATTRAN DC, STEINER G, WILSON DR, FENTON SSA: Hyperlipidemia after renal transplantation: Natural history and pathophysiology. Ann Intern Med 91:554-559, 1979
8. LOWRY RP, SOUTYS G, MANGEL R, KWITEROVITCH P, SNIDERMAN AD: Type II hyperlipoproteinemia, hyperapohetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: Prevalence and precipitating factors. Transplant Proc 19:2229-2232, 1987
9. KASISKE BL, UMEN AJ: Persistent hyperlipidaemia in renal transplant patients. Medicine 66:309-316, 1987
10. TELCI A, SALMAYENLI N, AYDIN AE, YAMANER S, SIVAS A, ELDEGEZ U: Serum lipids and apolipoprotein concentrations and plasma fibronectin concentrations in renal transplant patients. Eur J Clin Chem Clin Biochem 30:847-850, 1992
11. APANAY DC, NEYLAN JF, RAGAB MS, SGOUTAS DS: Cyclosporin increases the oxidizability of low-density lipoproteins in renal transplant recipients. Transplantation 58:663-669, 1994
12. STEINBERG D, PARTHASARATHY S, CAREW TE, KHOO JC, WITZTUM JL: Beyond cholesterol: Modifications of LDL that increase its atherogenicity. N Engl J Med 320:916-924, 1989
13. HENRIKSEN T, MAHONEY EM, STEINBERG D: Enhanced macrophage degradation of biologically modified low density lipoproteins. Arteriosclerosis 3:149-159, 1983
14. HABERLAND ME, FONG, D, CHENG L: Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241:215-218, 1988
15. YLÄ-HERTTUALA S, PALINSKI W, ROSENFELD ME, PATHASARATHY S, CAREW TC, BUTLER S, WITZTUM JL, STEINBERG D: Evidence for the presence of oxidatively modified LDL in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086-1095, 1989
16. BOYD HC, GOWN AM, WOLFBAUER G, CHAIT A: Direct evidence for a protein recognized by a monoclonal antibody against oxidatively-modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol 135:815-825, 1484
17. ESTERBAUER H, STRIEGI G, PUHL H, ROTHENEDER M: Continuous monitoring of in vitro oxidation of human LDL. Free Radical Res Commun 6:67-75, 1989
18. REGNSTROM J, NILSSON J, TORNVALL P, LANDOU C, HAMSTEN A: Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 334:1183-1186, 1992
19. CHAIT A: Methods for assessing lipid and lipoprotein oxidation. Curr Opin Lipid 3:389-394, 1992
20. SALONEN JT, YLÄ-HERTTUALA S, YAMAMOTO R, BUTLER S, KORPELA H, SALONEN R, NYYSSÖNEN K, PALINSKI W, WITZTUM JL: Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 339:883-887, 1992
21. SHEN MM, KRAUSS RM, LINDGREN FT, FORTE TM: Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res 22:236-244, 1981
22. KRAUSS RM, BURKE DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104, 1982
23. PACKARD CJ, SHEPHERD J, JOERNS S, GOTTO AM, TAUNTON OD: Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Biochim Biophys Acta 572:269-282, 1979
24. RUBENSTEIN B, STEINER G: Fractionation of human low density lipoprotein by column chromatography. Can J Biochem 22:1023-1028, 1976
25. AUSTIN MA, KRAUSS RM: Genetic control of low density lipoprotein subclasses. Lancet 2:592-595, 1986
26. AUSTIN MA, BRESLOW JL, HENNEKENS CH, BURING JE, WILLETT WC, KRAUSS RM: Low density lipoprotein subclass patterns and the risk of myocardial infarction. JAMA 260:1917-1921, 1988
27. KRAUSS RM: Relationship of intermediate and low density lipoprotein subspecies to risk of coronary artery disease. Am Heart J 113:578-582, 1987
28. CROUSE JR, PARKS JS, SCHEY HM, KAHL FR: Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 26:566-574, 1985
29. CAMPOS H, GENEST JR JJ, BLIJLEVENS E, MCNAMARA J, JENNER JL, ORDOVAS JM, WILSON PWF, SCHAEFER EJ: Low density particle size and coronary artery disease. Arterioscler Thromb 12:187-195, 1992
30. LABELLE M, KRAUSS RM: Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. J Lipid Res 31:1577-1588, 1990
31. AVILA EM, LOPEZ F, CAMEJO G: Properties of low density lipoprotein related to its interaction with arterial wall components. In vitro and vivo studies. Artery 4:36-60, 1978
32. DEGRAAF J, HAK-LEMMERS HL, HECTORS MC,. DEMACKER PN, HENDRIKS JC, STALENHOEF AFH: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscl Thromb 11:298-306, 1991
33. CHAIT A, BRAZG RL, TRIBBLE DL, KRAUSS RM: Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, Pattern B. Am J Med 94:350-356, 1993
34. KLEINVELD HA, HAK-LEMMERS HLM, STALENHOEF AFH, DEMACKER PNM: Improved measurement of low-density lipoprotein susceptibility to copper-induced oxidation: Application of a short procedure for isolating low-density lipoprotein. Clin Chem 38:2066-2072, 1992
35. REDGRAVE TG, ROBERTS DCK, WEST E: Separation of plasma lipoproteins by density gradient ultracentrifugation. Anal Biochem 65:42-49, 1975
36. BURSTEIN M, SCHOLNICK HR, MORFEN R: Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11:583-595, 1970
37. FRIEDEWALD WT, LEVY RI, FREDRICKSON DS: Estimation of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
38. JANSEN H, HOP W, VAN TOL A, BRUSCHKE AVG, BIRKENHÄGER JC: Hepatic lipase and lipoprotein lipase are not major determinants of low density lipoprotein subclass pattern in human subjects with coronary heart disease. Atherosclerosis 107:45-54, 1994
39. CORESH J, KWITEROVICH PO, SMITH HH, BACHORIK PS: Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 34:1687-1697, 1993
40. PALINSKI W, YLÄ-HERTTUALA S, ROSENFELD ME, BUTLER SW, SOCHER SA, PARTHASARATHY S, CURTISS LK, WITZTUM JL: Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10:325-335, 1990
41. JANSEN H, GHANEM H, KUYPERS HSAM, BIRKENHÄGER JC: Autoantibodies against malondialdehyde-modified LDL are enhanced in subjects with an LDL subclass B pattern. Atherosclerosis 115:255-262, 1995
42. COCKCROFT DW, GAULT MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
43. MOORE R, THOMAS D, MORGAN E, WHEELER D, GRIFFIN P, SALAMAN J, REES A: Abnormal lipid and lipoprotein profiles following renal transplantation. Transplant Proc 25:1060-1061, 1993
44. ALLEGRA V, MENGOZZI G, VASILE A: Lipoprotein lipids and apoproteins in healthy renal transplant recipients. Nephron 51:276-277, 1989
45. IBELS LS, REARDON MF, NESTEL PJ: Plasma post-heparin lipolytic activity and triglyceride clearance in uraemic and hemodialysis patients and renal allograft recipients. J Lab Clin Med 87:648-658, 1976
46. KOBAYASHI N, OKUBO M, MARUMO F, UCHIDA H, ENDO T, NAKAMURA H: De novo development of hypercholesterolemia and elevated high density lipoprotein cholesterol: Apoprotein AI ratio in patients with chronic renal failure following kidney transplantation. Nephron 35:237-240, 1983
47. IBELS LS, SIMONS LA, KING JO, WILLIAMS PF, NEALE FC, STEWART JH: Studies on the nature and causes of hyperlipemia of uremia maintenance dialysis and renal transplantalion. Q J Med 44:601-614, 1975
48. BAGDADE J, CASARETTO A, ALBERTS J: Effects of chronic uremia, hemodialysis and renal transplantation on plasma lipids and lipoproteins in man. J Lab Clin Med 87:38-48, 1976
49. MAGGI E, BELLAZZI R, GAZO A, SECCIA M, BELLOMO G: Autoantibodies against oxidatively-modified LDL in uraemic patients undergoing dialysis. Kidney Int 46:869-876, 1994
50. TAYLOR JE, SCOTT N, HILL A, BRIDGES A, HENDERSON IS, STEWART WK, BELCH JJF: Oxygen free radicals and platelet and granulocyte aggregahility in renal transplant patients. Transplantation 55:500-504, 1993
51. AUSTIN MA, BRUNZELL JD, FITCH WL, KRAUSS RM: Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 10:520-530, 1990